Back to results
US 2017/0000819 A1Published application
Novel ophthalmic composition and methods of use
AssigneeVeloce BioPharma, LLC
InventorsJoseph Capriotti, Kara Capriotti, Jesse Pelletier, Kevin Stewart
Life of this patent
Estimating the term…
Abstract
Described are stable topical formulations useful in the treatment of viral infection, demodex infection and bacterial infection of the eye, and methods of using the compositions for treating viral infection, demodex infection and bacterial infection of the eye.
Claims20
A stable ophthalmically acceptable gel composition comprising
- 0.15% to 1.5% povidone-iodine (PVP-I);
- 30% to 97% dimethyl sulfoxide (DMSO);
- 2.5% to 5% hydroxyethylcellulose;
- and
- water or isotonic co-solvent
- wherein, the composition is a topical ophthalmic gel, free of additional anti-inflammatory drug.
3 more elements
Dependencies are inferred from the claim text.